BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

1. BGF World Gold A2

  • Security

    BGF World Gold A2 USD

  • Fee

    2.48%

  • ISIN

    LU0055631609

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 13 holdings in BGF World Gold A2, where the largest holding is Agnico Eagle Mines (7.05), followed by Newmont (6.85) and Kinross Gold (6.69). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in BGF World Gold A2 and UBS Lux Equity Fund Biotech USD.

BGF World Gold A2 UBS Lux Equity Fund Biotech USD
1. Agnico Eagle Mines Ltd
Canada
7.05 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Newmont Corp
USA
6.85 %
2. Moderna Inc
9.21 %
3. Kinross Gold Corp
Canada
6.69 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Endeavour Mining Plc
UK
6.39 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Barrick Mining Corp
USA
6.1 %
5. AbbVie Inc
USA
4.91 %
6. Northern Star Resources Ltd
Australia
5.67 %
6. Gilead Sciences Inc
USA
4.66 %
7. Wheaton Precious Metals Corp
Canada
4.77 %
7. Amgen Inc
USA
4.43 %
8. Alamos Gold Inc
Canada
4.36 %
8. BioNTech SE
4.13 %
9. Lundin Gold Inc
Canada
4.08 %
9. Karuna Therapeutics Inc
3.75 %

The list of fund holdings was last updated on July 27, 2025.